| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |